Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Cancer

Date Submitted: Nov 21, 2022
Date Accepted: Aug 14, 2023

The final, peer-reviewed published version of this preprint can be found here:

An Actionable Expert-System Algorithm to Support Nurse-Led Cancer Survivorship Care: Algorithm Development Study

Pfisterer KJ, Lohani R, Janes E, Ng D, Wang D, Bryant-Lukosius D, Rendon R, Berlin A, Bender J, Brown I, Feifer A, Gotto G, Saha S, Cafazzo JA, Pham Q

An Actionable Expert-System Algorithm to Support Nurse-Led Cancer Survivorship Care: Algorithm Development Study

JMIR Cancer 2023;9:e44332

DOI: 10.2196/44332

PMID: 37792435

PMCID: 10585445

An actionable expert-system algorithm to support nurse-led cancer survivorship care: Algorithm development study

  • Kaylen J. Pfisterer; 
  • Raima Lohani; 
  • Elizabeth Janes; 
  • Denise Ng; 
  • Danny Wang; 
  • Denise Bryant-Lukosius; 
  • Ricardo Rendon; 
  • Alejandro Berlin; 
  • Jacqueline Bender; 
  • Ian Brown; 
  • Andrew Feifer; 
  • Geoffrey Gotto; 
  • Shumit Saha; 
  • Joseph A. Cafazzo; 
  • Quynh Pham

ABSTRACT

Background:

Comprehensive models of survivorship care are necessary to improve access and coordination of care. New models of care provide the opportunity to address the complexity of physical and psychosocial problems and long-term health needs experienced by patients following cancer treatment.

Objective:

This paper presents our expert-informed, rules-based, survivorship algorithm to build a nurse-led model of survivorship care to support men living with prostate cancer (PCa) with “no evidence of disease” (Ned) to support more timely decision-making, enhanced safety and continuity of care.

Methods:

An initial rule-set was developed and refined though working groups with clinical experts across Canada (e.g., nurse experts, physician experts, scientists) (n=20), and patient partners (n=3). Algorithm priorities were defined through a multidisciplinary consensus meeting with clinical nurse specialists, nurse scientists, nurse practitioners, urologic oncologists, urologists, and radiation oncologists (n=17). The system was refined and validated using nominal group technique.

Results:

Four levels of alert classification were established, initiated by responses on the EPIC-CP survey, and mediated by changes in minimal clinically important different alert thresholds, alert history, clinical urgency with patient autonomy influencing clinical acuity. Patient autonomy was supported through tailored education as a first line of response, and alert escalation depending on a patient-initiated request for a nurse consultation.

Conclusions:

The Ned algorithm is positioned to facilitate PCa nurse-led care models with a high nurse to patient ratio. This novel expert-informed PCa survivorship care algorithm contains a defined escalation pathway for clinically urgent symptoms while honoring patient preference. Though further validation is required through a pragmatic trial, we anticipate the Ned algorithm will support more timely decision-making, enhance continuity of care through automation of more frequent automated check points, while empowering patients to self-manage their symptoms more effectively than standard care.


 Citation

Please cite as:

Pfisterer KJ, Lohani R, Janes E, Ng D, Wang D, Bryant-Lukosius D, Rendon R, Berlin A, Bender J, Brown I, Feifer A, Gotto G, Saha S, Cafazzo JA, Pham Q

An Actionable Expert-System Algorithm to Support Nurse-Led Cancer Survivorship Care: Algorithm Development Study

JMIR Cancer 2023;9:e44332

DOI: 10.2196/44332

PMID: 37792435

PMCID: 10585445

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.